Stock Trader, Investor, Analyst and Trainer on Technical Picks, Recommendation on the index, Stock, Future, commodity, bank nifty trading, and Stock Tips
Cipla rises nearly 3% as company to market Eli Lilly#39;s diabetes drug Under this agreement, Lillyâs BASAGLAR that is manufactured by Lilly will be marketed and distributed in India by Cipla.
https://ift.tt/2s01YoW
from Moneycontrol Buzzing Stocks https://ift.tt/2Lv4lY6
via EMMKAY
No comments:
Post a Comment